The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Robert W. Sidwell

Institute for Antiviral Research

Utah State University

5600 Old Main Hill

Logan

USA

[email]@cc.usu.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Institute for Antiviral Research, Utah State University, 5600 Old Main Hill, Logan, USA. 1996 - 2007

References

  1. Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Sidwell, R.W., Barnard, D.L., Day, C.W., Smee, D.F., Bailey, K.W., Wong, M.H., Morrey, J.D., Furuta, Y. Antimicrob. Agents Chemother. (2007) [Pubmed]
  2. Respiratory syncytial virus infections: recent prospects for control. Sidwell, R.W., Barnard, D.L. Antiviral Res. (2006) [Pubmed]
  3. In vitro and in vivo influenza virus-inhibitory effects of viramidine. Sidwell, R.W., Bailey, K.W., Wong, M.H., Barnard, D.L., Smee, D.F. Antiviral Res. (2005) [Pubmed]
  4. Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control. Sidwell, R.W., Smee, D.F. Antiviral Res. (2003) [Pubmed]
  5. Inhibition of influenza virus infections in immunosuppressed mice with orally administered peramivir (BCX-1812). Sidwell, R.W., Bailey, K.W., Morrey, J.D., Wong, M.H., Baldwin, T.J., Smee, D.F. Antiviral Res. (2003) [Pubmed]
  6. Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza. Sidwell, R.W., Smee, D.F. Expert. Opin. Investig. Drugs (2002) [Pubmed]
  7. In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201. Sidwell, R.W., Smee, D.F., Huffman, J.H., Barnard, D.L., Bailey, K.W., Morrey, J.D., Babu, Y.S. Antimicrob. Agents Chemother. (2001) [Pubmed]
  8. Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice. Sidwell, R.W., Smee, D.F., Bailey, K.W., Burger, R.A. Int. Immunopharmacol. (2001) [Pubmed]
  9. Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201. Sidwell, R.W., Smee, D.F., Huffman, J.H., Barnard, D.L., Morrey, J.D., Bailey, K.W., Feng, W.C., Babu, Y.S., Bush, K. Antiviral Res. (2001) [Pubmed]
  10. Utilization of alpha-1-acid glycoprotein levels in the serum as a parameter for in vivo assay of influenza virus inhibitors. Sidwell, R.W., Wong, M.H., Bailey, K.W., Barnard, D.L., Jackson, M.K., Smee, D.F. Antivir. Chem. Chemother. (2001) [Pubmed]
  11. In vitro and in vivo assay systems for study of influenza virus inhibitors. Sidwell, R.W., Smee, D.F. Antiviral Res. (2000) [Pubmed]
  12. Influence of treatment schedule and viral challenge dose on the in vivo influenza virus-inhibitory effects of the orally administered neuraminidase inhibitor GS 4104. Sidwell, R.W., Bailey, K.W., Bemis, P.A., Wong, M.H., Eisenberg, E.J., Huffman, J.H. Antivir. Chem. Chemother. (1999) [Pubmed]
  13. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor. Sidwell, R.W., Huffman, J.H., Barnard, D.L., Bailey, K.W., Wong, M.H., Morrison, A., Syndergaard, T., Kim, C.U. Antiviral Res. (1998) [Pubmed]
  14. Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice. Sidwell, R.W., Huffman, J.H., Bailey, K.W., Wong, M.H., Nimrod, A., Panet, A. Antimicrob. Agents Chemother. (1996) [Pubmed]
 
WikiGenes - Universities